Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A. V. Dobrodumov is active.

Publication


Featured researches published by A. V. Dobrodumov.


International Journal of Nanomedicine | 2014

Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors.

Maxim A. Shevtsov; Boris P. Nikolaev; Ludmila Y. Yakovleva; Yaroslav Y. Marchenko; A. V. Dobrodumov; Anastasiya L Mikhrina; Marina G. Martynova; Olga A. Bystrova; Igor V Yakovenko; Alexander M. Ischenko

Superparamagnetic iron oxide nanoparticles (SPIONs) conjugated with recombinant human epidermal growth factor (SPION–EGF) were studied as a potential agent for magnetic resonance imaging contrast enhancement of malignant brain tumors. Synthesized conjugates were characterized by transmission electron microscopy, dynamic light scattering, and nuclear magnetic resonance relaxometry. The interaction of SPION–EGF conjugates with cells was analyzed in a C6 glioma cell culture. The distribution of the nanoparticles and their accumulation in tumors were assessed by magnetic resonance imaging in an orthotopic model of C6 gliomas. SPION–EGF nanosuspensions had the properties of a negative contrast agent with high coefficients of relaxation efficiency. In vitro studies of SPION–EGF nanoparticles showed high intracellular incorporation and the absence of a toxic influence on C6 cell viability and proliferation. Intravenous administration of SPION–EGF conjugates in animals provided receptor-mediated targeted delivery across the blood–brain barrier and tumor retention of the nanoparticles; this was more efficient than with unconjugated SPIONs. The accumulation of conjugates in the glioma was revealed as hypotensive zones on T2-weighted images with a twofold reduction in T2 relaxation time in comparison to unconjugated SPIONs (P<0.001). SPION–EGF conjugates provide targeted delivery and efficient magnetic resonance contrast enhancement of EGFR-overexpressing C6 gliomas.


Neuro-oncology | 2014

Tumor targeting using magnetic nanoparticle Hsp70 conjugate in a model of C6 glioma

Maxim A. Shevtsov; Ludmila Y. Yakovleva; Boris P. Nikolaev; Yaroslav Y. Marchenko; A. V. Dobrodumov; Kirill V. Onokhin; Yana S. Onokhina; Sergey A. Selkov; Anastasiia L. Mikhrina; Irina V. Guzhova; Marina G. Martynova; Olga A. Bystrova; Alexander M. Ischenko; Boris A. Margulis

BACKGROUND Superparamagnetic iron oxide nanoparticles (SPIONs), due to their unique magnetic properties, have the ability to function both as magnetic resonance (MR) contrast agents, and can be used for thermotherapy. SPIONs conjugated to the heat shock protein Hsp70 that selectively binds to the CD40 receptor present on glioma cells, could be used for MR contrast enhancement of experimental C6 glioma. METHODS The magnetic properties of the Hsp70-SPIONs were measured by NMR relaxometry method. The uptake of nanoparticles was assessed on the C6 glioma cells by confocal and electron microscopes. The tumor selectivity of Hsp70-SPIONs being intravenously administered was analyzed in the experimental model of C6 glioma in the MRI scanner. RESULTS Hsp70-SPIONs relaxivity corresponded to the properties of negative contrast agents with a hypointensive change of resonance signal in MR imaging. A significant accumulation of the Hsp70-SPIONs but not the non-conjugated nanoparticles was observed by confocal microscopy within C6 cells. Negative contrast tumor enhancement in the T2-weighted MR images was higher in the case of Hsp70-SPIONs in comparison to non-modified SPIONs. Histological analysis of the brain sections confirmed the retention of the Hsp70-SPIONs in the glioma tumor but not in the adjacent normal brain tissues. CONCLUSION The study demonstrated that Hsp70-SPION conjugate intravenously administered in C6 glioma model accumulated in the tumors and enhanced the contrast of their MR images.


Polymer Science Series B | 2010

Synthesis of multicentered polyimide initiators for the preparation of regular graft copolymers via controlled radical polymerization

T. K. Meleshko; D. M. Il’gach; N. N. Bogorad; N. V. Kukarkina; E. N. Vlasova; A. V. Dobrodumov; I. I. Malakhova; N. I. Gorshkov; V. D. Krasikov; A. V. Yakimanskii

Multicentered initiators for the controlled (pseudoliving) radical polymerization are synthesized via polymer analog transformation of hydroxyl-containing polyimides based on o-aminophenols. Conditions providing variations in the degree of functionalization of polyimides by initiating 2-bromoisobutyrate groups are determined, and optimum conditions for the preparation of macroinitators containing the above groups in each repeat polyimide unit are found. Via the method of controlled radical polymerization with the atom transfer on multicentered macroinitiators in the presence of complexes of univalent copper halides, graft copolymers of poly(methylmethacrylate) on polyimide backbone are obtained. Molecular-mass characteristics of graft copolymers are studied via multiple-detection size-exclusion liquid chromatography. Preparation of graft copolymers (polymer brushes) with a homogeneous grafting density and a homogeneous length of side chains necessitates grafting of the side chain on the polyimide initiator, which contains initiating groups in each repeat unit.


International Journal of Cancer | 2014

Effective immunotherapy of rat glioblastoma with prolonged intratumoral delivery of exogenous heat shock protein Hsp70

Maxim A. Shevtsov; Alexander V. Pozdnyakov; Anastasia L. Mikhrina; Ludmila Y. Yakovleva; Boris P. Nikolaev; A. V. Dobrodumov; Elena Y. Komarova; Darya A. Meshalkina; Alexander M. Ischenko; Emil Pitkin; Irina V. Guzhova; Boris A. Margulis

Chaperone Hsp70 can activate adaptive immunity suggesting its possible application as an antitumor vaccine. To assess the therapeutic capacity of Hsp70 we administered purified chaperone into a C6 glioblastoma brain tumor and explored the viability and tumor size as well as interferon gamma (IFNγ) production and cytotoxicity of lymphocytes in the treated animals. Targeted intratumoral injection of Hsp70 resulted in its distribution within the area of glioblastoma, and caused significant inhibition of tumor progression as confirmed by magnetic resonance imaging. The delay in tumor growth corresponded to the prolonged survival of tumor‐bearing animals of up to 31 days versus 20 days in control. Continuous administration of Hsp70 with an osmotic pump increased survival even further (39 days). Therapeutic efficacy was associated with infiltration to glioblastoma of NK cells (Ly‐6c+) and T lymphocytes (CD3+, CD4+ and CD8+) as well as with an increase in the activity of NK cells (granzyme B production) and CD8+ T lymphocytes as shown by IFNγ ELISPOT assay. Furthermore, we found that Hsp70 treatment caused concomitantly, with a tenfold elevated IFNγ production, an increase in anti‐C6 tumor cytotoxicity of lymphocytes. In conclusion, continuous intratumoral delivery of Hsp70 demonstrates high therapeutic potential and therefore could be applied in the treatment of glioblastoma.


Russian Journal of General Chemistry | 2007

Modification of films of heat-resistant polyimides by adding hydrosilicate and carbon nanoparticles of various geometries

I. V. Gofman; V. M. Svetlichnyi; V. E. Yudin; A. V. Dobrodumov; A. L. Didenko; I. V. Abalov; E. N. Korytkova; A. I. Egorov; V. V. Gusarov

The possibility of modifying the properties of poly(4,4′-oxydiphenylene)pyromellitimide films by introducing into prepolymer solutions nanoparticles of various compositions and structures [hydrosilicate nanoparticles in the form of layered structures (montmorillonite) and nanotubes; carbon nanofibers] was examined. New intercalating agents, tetranuclear aromatic diamines, were suggested for pretreatment of montmorillonite prior to introduction into heat-resistant polymers. The mechanical characteristics of the nanocomposites with hydrosilicate nanotubes can be optimized by chemical pretreatment of the nanotubes prior to introduction into the polymer matrix. Introduction of the above-named nanoparticles into the polymer matrix appreciably increases the elastic modulus of the material. The largest increase in the elastic modulus is observed with hydrosilicate nanotubes of the chrysotile structure, coated with an aromatic modifier.


Neoplasia | 2015

Recombinant interleukin-1 receptor antagonist conjugated to superparamagnetic iron oxide nanoparticles for theranostic targeting of experimental glioblastoma.

Maxim A. Shevtsov; Boris P. Nikolaev; Ludmila Y. Yakovleva; A. V. Dobrodumov; Alexander V. Zhakhov; Anastasiy L. Mikhrina; Emil Pitkin; Marina A. Parr; Valerii I. Rolich; Andrei S. Simbircev; Alexander M. Ischenko

Cerebral edema commonly accompanies brain tumors and contributes to neurologic symptoms. The role of the interleukin-1 receptor antagonist conjugated to superparamagnetic iron oxide nanoparticles (SPION–IL-1Ra) was assessed to analyze its anti-edemal effect and its possible application as a negative contrast enhancing agent for magnetic resonance imaging (MRI). Rats with intracranial C6 glioma were intravenously administered at various concentrations of IL-1Ra or SPION–IL-1Ra. Brain peritumoral edema following treatment with receptor antagonist was assessed with high-field MRI. IL-1Ra administered at later stages of tumor progression significantly reduced peritumoral edema (as measured by MRI) and prolonged two-fold the life span of comorbid animals in a dose-dependent manner in comparison to control and corticosteroid-treated animals (P < .001). Synthesized SPION–IL-1Ra conjugates had the properties of negative contrast agent with high coefficients of relaxation efficiency. In vitro studies of SPION–IL-1Ra nanoparticles demonstrated high intracellular incorporation and absence of toxic influence on C6 cells and lymphocyte viability and proliferation. Retention of the nanoparticles in the tumor resulted in enhanced hypotensive T2-weighted images of glioma, proving the application of the conjugates as negative magnetic resonance contrast agents. Moreover, nanoparticles reduced the peritumoral edema confirming the therapeutic potency of synthesized conjugates. SPION–IL-1Ra nanoparticles have an anti-edemal effect when administered through a clinically relevant route in animals with glioma. The SPION–IL-1Ra could be a candidate for theranostic approach in neuro-oncology both for diagnosis of brain tumors and management of peritumoral edema.


Journal of Controlled Release | 2015

70-kDa heat shock protein coated magnetic nanocarriers as a nanovaccine for induction of anti-tumor immune response in experimental glioma

Maxim A. Shevtsov; Boris P. Nikolaev; Liudmila Yu. Yakovleva; Marina A. Parr; Yaroslav Y. Marchenko; Igor Eliseev; Anna N. Yudenko; A. V. Dobrodumov; Olga Zlobina; Alexander V. Zhakhov; Alexander M. Ischenko; Emil Pitkin; Gabriele Multhoff

Nanovaccines based on superparamagnetic iron oxide nanoparticles (SPIONs) provide a novel approach to induce the humoral and cell-based immune system to fight cancer. Herein, we increased the immunostimulatory capacity of SPIONs by coating them with recombinant heat shock protein 70 (Hsp70) which is known to chaperone antigenic peptides. After binding, Hsp70-SPIONs deliver immunogenic peptides from tumor lysates to dendritiс cells (DCs) and thus stimulate a tumor-specific, CD8+ cytotoxic T cell response. We could show that binding activity of Hsp70-SPIONs to the substrate-binding domain (SBD) is highly dependent on the ATPase activity of its nucleotide-binding domain NBD), as shown by (31)P NMR spectroscopy. Immunization of C6 glioma-bearing rats with DCs pulsed with Hsp70-SPIONs and tumor lysates resulted in a delayed tumor progression (as measured by MRI) and an increased overall survival. In parallel an increased IFNγ secretion were detected in the serum of these animals and immunohistological analysis of subsequent cryosections of the glioma revealed an enhanced infiltration of memory CD45RO+ and cytotoxic CD8+ T cells. Taken together the study demonstrates that magnetic nanocarriers such as SPIONs coated with Hsp70 can be applied as a platform for boosting anti-cancer immune responses.


Drug Design Development and Therapy | 2014

neurotherapeutic activity of the recombinant heat shock protein hsp70 in a model of focal cerebral ischemia in rats

Maxim A. Shevtsov; Boris P. Nikolaev; Ludmila Y. Yakovleva; A. V. Dobrodumov; Anastasiy S Dayneko; Alexey Shmonin; Timur D. Vlasov; Elena V Melnikova; Alexander D Vilisov; Irina V. Guzhova; Alexander M. Ischenko; Anastasiya L Mikhrina; Oleg V. Galibin; Igor V Yakovenko; Boris A. Margulis

Recombinant 70 kDa heat shock protein (Hsp70) is an antiapoptotic protein that has a cell protective activity in stress stimuli and thus could be a useful therapeutic agent in the management of patients with acute ischemic stroke. The neuroprotective and neurotherapeutic activity of recombinant Hsp70 was explored in a model of experimental stroke in rats. Ischemia was produced by the occlusion of the middle cerebral artery for 45 minutes. To assess its neuroprotective capacity, Hsp70, at various concentrations, was intravenously injected 20 minutes prior to ischemia. Forty-eight hours after ischemia, rats were sacrificed and brain tissue sections were stained with 2% triphenyl tetrazolium chloride. Preliminary treatment with Hsp70 significantly reduced the ischemic zone (optimal response at 2.5 mg/kg). To assess Hsp70’s neurotherapeutic activity, we intravenously administered Hsp70 via the tail vein 2 hours after reperfusion (2 hours and 45 minutes after ischemia). Rats were then kept alive for 72 hours. The ischemic region was analyzed using a high-field 11 T MRI scanner. Administration of the Hsp70 decreased the infarction zone in a dose-dependent manner with an optimal (threefold) therapeutic response at 5 mg/kg. Long-term treatment of the ischemic rats with Hsp70 formulated in alginate granules with retarded release of protein further reduced the infarct volume in the brain as well as apoptotic area (annexin V staining). Due to its high neurotherapeutic potential, prolonged delivery of Hsp70 could be useful in the management of acute ischemic stroke.


Russian Journal of Organic Chemistry | 2009

Tautomerism and conformational isomerism of mercaptoacetylhydrazones of aliphatic and aromatic aldehydes

A. Yu. Ershov; I. V. Lagoda; S. I. Yakimovich; V. V. Pakal’nis; I. V. Zerova; A. V. Dobrodumov; V. V. Shamanin

Mercaptoacetylhydrazones of aliphatic and aromatic aldehydes exist in the solutions as tautomeric mixtures of open-chain and cyclic 1,3,4-thiadiazine forms. The linear hydrazone form consists of a set of isomers due to the configurational and conformational isomerism. At growing bulk of the alkyl substituent at the C=N bond of the aliphatic aldehydes derivatives decreases the fraction of the cyclic tautomer; therewith the logarithms of the constants of the chain-ring tautomeric equilibrium correlate with the steric constants of the alkyl substituents. In the series of the aromatic aldehydes mercaptoacetylhydrazones the linear tautomer prevails, and the equilibrium position is insignificantlyt affected at variation of the electronic characteristics of the substituents in the aromatic ring.


Applied Biochemistry and Microbiology | 2010

Isolation, identification, and characteristics of the phytotoxin produced by the fungus Alternaria cirsinoxia

A. O. Berestetskii; O. S. Yuzikhin; A. S. Katkova; A. V. Dobrodumov; D. E. Sivogrivov; L. V. Kolombet

An individual substance (20 mg/l) exhibiting phytotoxic properties, which, on the basis its spectral characteristics, was identified as zinniol, was obtained from the fungus Alternaria cirsinoxia. The nonspecific activity of this phytotoxin, with respect to plants of different families, was demonstrated. The minimum concentration (200 μg/ml) at which zinniol damages creeping thistle leaves and the median inhibition concentration (IC50) for rat embryonic fibroblasts (264 μg/ml) were determined.

Collaboration


Dive into the A. V. Dobrodumov's collaboration.

Top Co-Authors

Avatar

Yaroslav Y. Marchenko

Saint Petersburg State University

View shared research outputs
Top Co-Authors

Avatar

Emil Pitkin

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Boris A. Margulis

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Irina V. Guzhova

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

E. F. Panarin

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

O. V. Nazarova

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

E. N. Vlasova

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Marina A. Parr

Saint Petersburg State University

View shared research outputs
Top Co-Authors

Avatar

T. N. Nekrasova

Russian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Anastasiya L Mikhrina

I. M. Sechenov Institute of Evolutionary Physiology and Biochemistry

View shared research outputs
Researchain Logo
Decentralizing Knowledge